NIH Clinical Trial Diversity Act of 2023

This bill requires National Institutes of Health (NIH)-funded research organizations to include specific diversity goals in applications for clinical trials involving drugs, devices, biological products, or behavioral interventions. It mandates measurable recruitment and retention targets based on race, ethnicity, age, and sex, along with detailed plans to analyze results by these demographics and share annual demographic data with the NIH. The bill also requires training on diversity in clinical trials and sets out mechanisms to reduce participant burdens (e.g., virtual visits, flexible scheduling). These requirements apply to all NIH-funded clinical trials seeking approval or funding, directly affecting researchers and institutions conducting such studies.